Summary of project PR000268
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000268. The data can be accessed directly via it's Project DOI: 10.21228/M84S4K This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Project ID: | PR000268 |
| Project DOI: | doi: 10.21228/M84S4K |
| Project Title: | Urine metabolomics to track disease progression in DMD |
| Project Summary: | Duchenne Muscular Dystrophy (DMD) is an X-linked recessive form of muscular dystrophy that affects males via a mutation in the gene for the muscle protein, dystrophin. Progression of the disease results in severe muscle loss, ultimately leading to paralysis and death. Steroid therapy has been a commonly employed method for reducing the severity of symptoms. This study aims to quantify the urine levels of amino acids and organic acids in patients with DMD both with and without steroid treatment. Track the progression of DMD in patients who have provided multiple urine samples. |
| Institute: | University of Florida |
| Department: | Physiology and Functional Genomics |
| Last Name: | Walter |
| First Name: | Glenn |
| Address: | - |
| Email: | glennw@ufl.edu |
| Phone: | - |
Summary of all studies in project PR000268
| Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
|---|---|---|---|---|---|---|---|---|
| ST000336 | Targeted LC/MS of urine from boys with DMD and controls | Homo sapiens | University of Florida | MS | 2023-08-01 | 1 | 58 | Uploaded data (1.5M) |
